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Abstract
Background: The Yusho poisoning incident, which was caused by rice bran oil contaminated with
polychlorinated biphenyls (PCBs), polychlorinated quarterphenyls (PCQs) and polychlorinated
dibenzofurans (PCDFs) generated by heat denaturation of PCB, occurred in 1968 in western Japan.
Annual physical, dermatological, dental, ophthalmological and laboratory examinations were
conducted for Yusho patients after the incident. From 2001, blood levels of individual PCDF
congeners were also measured. The blood levels of 2,3,4,7,8-pentachlorodibenzofuran (2,3,4,7,8-
PeCDF), PCBs and PCQs in Yusho patients were found to be significantly higher than those of the
general population. We investigated the relationships between blood concentrations of 2,3,4,7,8-
PeCDF, PCBs and PCQs in Yusho patients and the items measured in the annual medical
examination.
Methods: Medical and laboratory examination data from 501 Yusho patients enrolled in the study
from 2001 to 2004 were analyzed. The relationships between blood 2,3,4,7,8-PeCDF, PCB and
PCQ concentrations and medical/laboratory examination data were investigated using principal
components and logistic regression analyses.
Results: Serum Concentrations of 2,3,4,7,8-PeCDF, PCBs and PCQs in blood tended to correlate
with either acneform eruptions, black comedones, cutaneous and mucosal pigmentation, and
hypersecretion of meibomian glands as well as general fatigue, headaches, cough/sputum, abdominal
pain, arthralgia, increased blood sugar, increased serum γ-GTP and decreased total bilirubin. The
majority of these signs and symptoms are included in the diagnostic criteria for Yusho.
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Conclusion: After Yusho patients had suffered chronic exposure to these chlorinated compounds
for more than 35 years, the serum concentration of 2,3,4,7,8-PeCDF in blood was significantly
related to arthralgia and decreased albumin/globulin (A/G) ratio; the serum concentration of PCBs
was significantly related to ophthalmologic symptoms; and the serum concentration of PCQ to
increased total cholesterol. These findings suggest that the co-contaminants may affect other
functions than those originally associated with Yusho.
Background
Yusho was a food poisoning incident that occurred in
western Japan in 1968 [1-8]. When first reported, the food
poisoning incident known as Yusho was considered to be
caused by polychlorinated biphenyls (PCBs). However,
following a number of studies, it is now considered to be
caused by complex poisoning with polychlorinated quar-
terphenyls (PCQs) and polychlorinated dibenzofurans
(PCDFs) [3-6]. Thirty-seven years have passed since the
Yusho incident occurred, and more than 1,800 patients
are known to have been affected.
Yusho patients are known to present with various symp-
toms related to the skin, eyes and teeth, and have abnor-
mal findings on physical examinations [8-14]. The
severity of symptoms in Yusho patients has gradually
improved over the past 37 years. However, a number of
patients still suffer from specific Yusho symptoms [3,4,8].
The initial diagnostic criteria published in 1968 were
mainly: 1) proven history of ingestion of contaminated
rice bran oil; 2) prominent dermatological, ophthalmo-
logical and mucosal signs; and 3) several nonspecific gen-
eral signs and symptoms. Hyperglyceridemia, pulmonary
disorders, intractable headache, elevated blood PCB con-
centrations and specific PCB patterns on gas chromatogra-
phy were added to the initial diagnostic criteria in 1972
and 1976. Blood PCQ concentrations were added to the
criteria in 1981 [3].
With recent advances in techniques for measuring individ-
ual PCDF congeners, it has become possible to precisely
measure 2,3,4,7,8-pentachlorodibenzofuran (2,3,4,7,8-
PeCDF) blood concentrations using as little as 5 ml of
blood [17,18]. Thus, measurements of 2,3,4,7,8-PeCDF
blood concentrations have been initiated since 2001 in
the routine mass screening of Yusho patients. The mean
blood concentrations of PeCDF in these patients have
been shown to be more than 10 times higher than those
in normal controls [3]. In 2004, the blood 2,3,4,7,8-
PeCDF concentration was added to the present diagnostic
criteria (Table 1).
In this study, we analyzed the results of medical examina-
tions of Yusho patients whose blood 2,3,4,7,8-PeCDF
concentrations were measured from 2001 to 2004 (33 to
37 years after the occurrence of the Yusho disaster), and
investigated the relationships among the 2,3,4,7,8-
PeCDF, PCB and PCQ blood concentrations and the clin-
ical data from physical and laboratory examinations.
Methods
Subjects and medical check items
Since immediately after the incident occurred, the Yusho
Study Group has conducted annual health checks of
Yusho patients. Between 2001 and 2004, a total of 501
individuals (81 individuals in 2001, 371 in 2002, 343 in
2003 and 292 in 2004, including multiple health checks)
underwent the Yusho mass screening. In addition to
blood PeCDFs, PCBs and PCQs serum concentrations,
241 check items (52 items in a questionnaire, 55 physical
and laboratory examinations, 21 dermatological exami-
nations, 108 dental examinations, and 5 ophthalmologi-
cal examinations) were carried out (Table 2).
Statistical analysis
The relationships between blood 2,3,4,7,8-PeCDF con-
centrations(serum) and the physical/laboratory test items
were analyzed using logistic regression analysis. Since the
serum half-life of 2,3,4,7,8-PeCDF is long and the present
blood concentrations are well correlated with the amount
of exposure at the time of the incident, the correlations
with these was examined [19]. Logistic regression analysis
uses a formula to relate several explanatory variables to
objective ones (2 values). We used the following equation
which included results [y] and several factors [x1, x2, ..., xn]
affecting these results with βi as coefficients
g(x) = β0+β1x1+β2x2+ ...+βnxn
y = eg(x)/(eg(x)+1)
To conduct a logistic regression analysis, we conducted a
principal component analysis as an auxiliary analysis to
decide the explanatory variables. Specifically, of the 241
items examined in the Yusho medical checkup, the princi-
pal component analysis was conducted on 172 items,
except for those related to frequency. As a result, examina-
tion items with 1 or higher eigenvalues and high factor
scores in the principal component analysis were used as
representative variables. In deciding the representative
variables, items with high factor scores were not selected
mechanically, but the following criteria were considered:Environmental Health 2008, 7:47 http://www.ehjournal.net/content/7/1/47
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(1) Items included in the criteria.
(2) Items considered to be medically significant.
(3) A weak factor representing an item selected by multi-
ple factors.
Furthermore, we confirmed that items whose associations
with Yusho have been indicated were not overlooked, by
reference to the criteria. We extracted 49 items, including
13 questionnaire-related items, 11 physical and labora-
tory examination items, 10 dermatological examination
items, 12 dental examination items and 3 ophthalmolog-
Table 1: Diagnostic criteria for Yusho (updated)
The diagnostic criteria for Yusho were revised on October 26, 1972; supplemented on June 14, 1976; and an item related to blood polychlorinated 
quarterphenyl (PCQ) level was added on June 16, 1981. The study group of Yusho started to measure blood levels of dioxins in annual medical 
check-ups from 2001. It was considered appropriate to add an item corresponding to the blood 2,3,4,7,8-PeCDF level; therefore the criteria were 
supplemented and further revised on September 29, 2004.
Conditions of the incident
1. Proof that Kanemi rice bran oil contaminated with polychlorinated biphenyls (PCBs) was ingested.
2. There are also some cases in which PCB is transferred from mothers with Yusho to their children.
3. Familial occurrence is also seen in many cases.
Important manifestations
1. Acneform eruptions
Black comedones* seen on the face, buttocks and other intertriginous sites; comedones with inflammatory manifestations; and subcutaneous cysts 
with atheroma-like contents that tended to suppurate.
2. Pigmentation
Pigmentation of the face, palpebral conjunctivae, gingivae**, and nails etc. (including so-called 'black babies').
3. Hypersecretion of the meibomian glands.
4. Unusual composition and concentration of PCBs in the blood.
5. Abnormal level of blood PCQ
(1) ≥ 0.1 ppb: an abnormally high concentration.
(2) 0.03 to 0.09 ppb: the boundary between high and normal concentrations.
(3) ≤ 0.02 ppb (detection limit): normal concentration.
6. Abnormal level of blood PeCDF
(1) ≥ 50 pg/g lipids: an abnormally high concentration.
(2) 30 to 50 pg/g lipids: a relatively high concentration.
(3) < 30 pg/g lipids: normal concentration.
Standard symptoms and findings
1. Subjective symptoms
(1) General fatigue
(2) Headaches, dull headaches
(3) Paresthesia of the extremities (abnormal sensation)(4) Increased eye discharge
(5) Cough and sputum
(6) Inconstant abdominal pain
(7) Altered menstruation
2. Objective findings
(1) Manifestation of bronchitis
(2) Deformation of nails
(3) Bursitis
(4) Increased neutral fat in the serum
(5) Increased serum γ-glutamyl transpeptidase (γ-GTP)
(6) Decrease in serum bilirubin
(7) Small-for-date baby
(8) Growth retardation and dental abnormality (retarded eruption of permanent teeth)
* Black comedones (other sites):
black comedones appearing on body parts other than the face, auricle, and trunk
** Palatal findings
Palatal lesions known to occur in Yusho patients include pigmentation and parakeratosis in the gingiva, dental root dysplasia, and odontatrophia.
Palatal findings from examinations in Yusho patients are recorded as follows:
(1) The upper teeth and lower teeth are each divided into 3 sites:
site 1 = 7–4, site 2 = 3-3, and site 3 = 4–7.
(2) Pigmentation patterns are divided into the following patterns recognized in Yusho patients:
Condition 1 = diffuse, Condition 2 = punctate, Condition 3 = linear,
Condition 4 = zonal, Condition 5 = cloudy, Condition 6 = island shapedEnvironmental Health 2008, 7:47 http://www.ehjournal.net/content/7/1/47
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ical examination items, as representative variables. (Table
3)
Furthermore, the following patterns were set as objective
variables for our logistic regression analyses:
2,3,4,7,8-PeCDF blood concentration(serum)
2 categories: [≥ 50 pg/g lipids] and [< 50 pg/g lipids] (as
indicated by the diagnostic criteria [3])
PCB blood concentration(serum)
2 categories: [≥ 2.0 ppb] and [< 2.0 ppb] (Categorized by
median value)
PCQ blood concentration(serum)
2 categories: [≥ 0.10 ppb] and [< 0.10 ppb] (as indicated
by the diagnostic criteria [3])
Table 2: Annual medical check examination sheet of Yusho patients
(1). Laboratory examination
Blood concentrations of PCB- and dioxin-related compounds
Total PCB, Peak 1, Peak 2, Peak 3, PCB pattern, CB ratio, Total PCQ, Dioxin-related compounds
Urinalysis (Protein, Sugar, Occult blood, Urobilinogen, pH)
Hematological examination
ESR (1-hour), ESR (2-hour), WBC, RBC, Hb, Ht, MCV, MCH, MCHC, PLT
Blood chemistry
T-Bil, D-Bil, GOT, GPT, TP, Alb, albumin/globulin(A/G) ratio, ZTT, TTT, ALP, LAP, γ-GTP, ChE, LDH,
CPK, TC, HDL-chol, TG, β-lip, BUN, Cre, Na, K, Ca, P, Amy, blood sugar level
Immunological examination (HBs antigen, α-fetoprotein)
(2). Interview and physical examination
Life history (Alcohol, Smoking)
Chief complaint
Past history(Before the incident, After the incident)
Subjective symptoms
General fatigue, Headache, Cough, Sputum, Abdominal pain, Diarrhea, Constipation
Numbness, Arthralgia, menstruation disorders
Physical examination
Body height, Body weight, Heart rate, Blood pressure, Nutrition, Heart sounds, Respiratory sounds,
Chest radiography, ECG, Abdominal ultrasonography,
Hepatomegaly, Splenomegaly, Edema, Lymphadenopathy, Tendon reflex, Sensory examination,
(3). Dermatological examination
Interview
Recent tendency to purulent skin eruptions, Recent recurrence of cystic lesions,
Past history of acneform eruptions, Past history of pigmentation,
Physical examination (severity and sites)
Black comedones, Acneform eruptions, Scar formation, Pigmentation, Nail deformity,
(4). Dental examination
Chief complaint
Toothache, Gingival bleeding, Pus discharge, Gingival swelling, Feeling of tooth extrusion, Pigmentation
Items for oral examination (No/Yes, site)
Gingivitis, Marginal periodontitis, Retarded eruptions of permanent teeth,
Tooth pigmentation, Odontogenesis imperfecta, Abnormal occlusion, Other findings,
Mucosal pigmentation (severity, site, *pattern, **color)
Upper gingivae, Lower gingivae, Rt. buccal mucosa, Lt. buccal mucosa, Palate,
Upper lip, Lower lip
Teeth radiograph (No/Yes)
*Selection items for pattern (Diffuse, Spotted, Band-like, Linear, Faint, Scattered)
**Selection items for color (Black, Brownish, Dark-brownish)
(5). Ophthalmological examination
Subjective symptoms (Abnormal discharge from the eyes)
Objective symptoms
Edema of the eyelid, Conjunctival pigmentation, Cysts of meibomian glands,
Cheesy secretion from meibomian glands,Environmental Health 2008, 7:47 http://www.ehjournal.net/content/7/1/47
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Other examination items
The 49 factors extracted by the principal component anal-
ysis were classified into normal and abnormal categories
considering the characteristics of the data for each test
item, from the following viewpoints:
(1) Factors for which the presence or absence of symp-
toms was confirmed by two steps in the medical checkup
by a doctor were classified into two steps of presence or
absence.
Table 3: Variables selected for principal components analysis
No. Variables Factor Score Examination classification
1 Pigmentation of lower gingivae 0.735 Dental examination
2 Blood sugar (increase) 0.443 Laboratory examination
3 Abdominal pain 0.408 Questionnaire
4 Past history of pigmentation 0.498 Dermatological examination
5A r t h r a l g i a 0.437 Questionnaire
6 Pigmentation of the upper lip (diffuse) 0.401 Dental examination
7 Triacylglycerol (increase) 0.361 Laboratory examination
8 Sputum 0.307 Questionnaire
9 Mean corpuscular volume (increase) 0.419 Laboratory examination
10 γ-GTP (increase) 0.367 Laboratory examination
11 Pigmentation of the upper lip (band-like) 0.581 Dental examination
12 albumin/globulin(A/G) ratio (decrease) -0.471 Laboratory examination
13 General fatigue -0.327 Questionnaire
14 Pigmentation (toe nails) 0.447 Dermatological examination
15 Tooth pigmentation 0.336 Dental examination
16 Pigmentation of the palatal mucosa 0.204 Dental examination
17 Pigmentation of the right buccal mucosa (band-like) 0.339 Dental examination
18 Past history (after the incident) 0.241 Questionnaire
19 Dental chief complaint 0.389 Dental examination
20 Nail deformity -0.272 Dermatological examination
21 Numbness 0.208 Questionnaire
22 Pigmentation (face) 0.280 Dermatological examination
23 Abnormal discharge from the eyes -0.297 Ophthalmological examination
24 Abnormal respiratory sounds 0.295 Physical examination
25 Pigmentation (left. buccal mucosa) 0.266 Dental examination
26 Total cholesterol (increase) 0.246 Laboratory examination
27 Cough 0.192 Questionnaire
28 Past history (Before the incident) 0.246 Questionnaire
29 Acneform eruptions (other sites) 0.297 Dermatological examination
30 Mucosal pigmentation of upper gingivae (linear) 0.363 Dental examination
31 Cheesy secretion from meibomian glands -0.260 Ophthalmological examination
32 Presence of hepatomegaly -0.317 Questionnaire
33 Direct-bilirubin (increase) 0.225 Laboratory examination
34 Abnormal heart sounds 0.239 Questionnaire
35 potassium level 0.286 Laboratory examination
36 Acneform eruptions (trunk) 0.216 Dermatological examination
37 Pigmentation (fingernails) 0.231 Dermatological examination
38 Malocclusion 0.274 Dental examination
39 Black comedones (other sites) -0.323 Dermatological examination
40 Urinalysis protein 0.363 Laboratory examination
41 Systolic blood pressure (low) -0.294 Questionnaire
42 Toothache 0.311 Dental examination
43 Edema of the eyelids 0.305 Ophthalmological examination
44 Headache 0.188 Questionnaire
45 Chief complaint -0.224 Questionnaire
46 Pigmentation of the mucosa of the upper lip (spotted) 0.292 Dental examination
47 Black comedones (face) 0.240 Dermatological examination
48 Total bilirubin (increase) 0.225 Laboratory examination
49 Past history of acneform eruptions 0.248 Dermatological examinationEnvironmental Health 2008, 7:47 http://www.ehjournal.net/content/7/1/47
Page 6 of 11
(page number not for citation purposes)
(2) Factors whose measurement results had normal value
standards, such as blood test results, were classified into
normal or abnormal.
(3) Items relevant to subjective symptoms, like sputum,
arthralgia and general fatigue, were classified into "nor-
mal" or "abnormal" for each patient.
(4) Items evaluated into five grades (-, ±, +, ++ and +++)
of symptoms, such as severity of pigmentation, were clas-
sified into two groups, based on the criterion of "+" or
above, to determine the presence of symptoms.
To conduct analyses on the above 3 patterns, 2,3,4,7,8-
PeCDF, PCB and PCQ blood concentrations were added
to the explanatory variables. SPSS11.5J for Windows was
used for the analyses.
Results
2,3,4,7,8-PeCDF blood concentration as an objective var-
iable, PCB and PCQ blood concentrations, blood glucose
level, arthralgia, gender, total bilirubin, black comedones,
acneform eruption, past history of skin pigmentation and
acneform eruption, increased A/G ratio, abnormal respi-
ratory sounds, blood potassium level, and total choles-
terol showed less than a 0.05 level of significance. Most of
these items are considered characteristic symptoms of
Yusho. Even when PCB and PCQ blood concentrations
are excluded from the explanatory variables, older age, A/
G ratio, general fatigue, arthralgia, gender and oral pig-
mentation showed less than a 0.05 level of significance.
In contrast, when 49 factors were extracted by the princi-
pal component analysis (PCB and PCQ as objective varia-
bles, 2,3,4,7,8-PeCDF blood concentration as an
explanatory variable), PCQ and PCB blood concentra-
tions, arthralgia, presence or absence of previous history
since 1968, A/G ratio and blood glucose level indicated a
significance probability of ≤ 0.05 for the 2,3,4,7,8-PeCDF
blood concentration. (Table 4)
PCB blood level as an objective variable, 2,3,4,7,8-PeCDF
blood concentration, sputum, age, female gender, past
history of pigmentation and acneform eruption, toe nail
pigmentation, hepatomegaly, headache, cheesy secretion
from meibomian glands, total bilirubin, and general
fatigue showed less than a 0.05 level of significance. When
2,3,4,7,8-PeCDF blood concentration was excluded from
the explanatory variables, age, sputum, past history of pig-
mentation, total bilirubin, PCQ blood concentration, toe
nail pigmentation, arthralgia, presence of a chief dental
complaint, headache, and cheesy secretion from meibo-
mian glands were significantly correlated with PCB blood
concentrations.
In contrast, when 49 factors were extracted by the princi-
pal component analysis (2,3,4,7,8-PeCDF and PCQ as
objective variables, PCB blood concentration as an
explanatory variable), items which showed less than a
0.05 level of significance for PCB blood concentration
(explanatory variable) included 2,3,4,7,8-PeCDF blood
concentration and excessive eye discharge. (Table 5)
PCQ blood concentration as an objective variable, tooth
pigmentation, arthralgia, γ-GTP, total bilirubin, cheesy
secretion from meibomian glands, general fatigue, total
cholesterol, toe nail pigmentation, female gender, and
oral mucosa pigmentation all showed less than a 0.05
level of significance. When 2,3,4,7,8-PeCDF blood con-
centration was excluded from the explanatory variables,
past history of pigmentation, tooth pigmentation, PCB
blood concentrations, acneform eruption, abdominal
pain, pigmentation, and total cholesterol were signifi-
cantly correlated with PCQ blood concentrations. (Table
6)
Discussion
PCBs, PCQs and PCDFs are known as the causative agents
of Yusho. The results from this study show that, the con-
centrations of 2,3,4,7,8-PeCDF, PCB and PCQ in blood
were strongly related. The blood concentrations of
2,3,4,7,8-PeCDF, PCB and PCQ tended to correlate with
older age, as adult victims were considered to have eaten
greater amounts of the contaminated oil compared with
child victims when the contaminated oil was available in
shops in 1968. The blood concentrations of 2,3,4,7,8-
PeCDF, PCB and PCQ also tended to correlate with
female gender. This may be attributed to the fact that these
chlorinated compounds are highly lipophilic and accu-
mulate in adipose tissue [3]. Females who have more adi-
pose tissue may have thus accumulated more 2,3,4,7,8-
PeCDF, PCB and PCQ.
In our study, the blood concentrations of 2,3,4,7,8-
PeCDF, PCB and PCQ also tended to correlate with acne-
form eruptions, black comedones, cutaneous and
mucosal pigmentation, and hypersecretion of meibomian
glands, in addition to general fatigue, headaches, cough,
sputum, abdominal pain, increased serum γ-GTP, and
decreased total bilirubin. These signs and symptoms are
all included in the present diagnostic criteria of Yusho
(Table 1). In addition to the symptoms listed in the diag-
nostic criteria, arthralgia was frequently correlated to
2,3,4,7,8-PeCDF, PCB and PCQ blood concentrations.
Using the 2,3,4,7,8-PeCDF blood concentration as an
objective variable, cases including or not including the
PCB and PCQ concentrations as explanatory variables
were compared. As a result, arthralgia and A/G ratio were
related to the 2,3,4,7,8-PeCDF blood concentration.Environmental Health 2008, 7:47 http://www.ehjournal.net/content/7/1/47
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Using the PCB blood concentration as an objective varia-
ble, cases including or not including the 2,3,4,7,8-PeCDF
concentration as an explanatory variable were compared.
As a result, PCB blood concentration was strongly related
to ophthalmological symptoms.
The PCQ blood concentration was related to cutaneous,
oral and ophthalmological manifestations, increased γ-
GTP, and increased total cholesterol. When the 2,3,4,7,8-
PeCDF blood concentration was excluded in the explana-
tory variables, oral pigmentation and increased total cho-
Table 4: Results of logistic regression analysis(2,3,4,7,8-PeCDF blood level as an objective variable)
List of explanatory variables which showed less than 0.10 level of significance when 2,3,4,7,8-PeCDF blood level (2 categories) and the factors 
selected by the principal components analysis were used as objective variables and explanatory variables, respectively
Explanatory 
variables
β Standard deviation Wald Significance
probability
Exp (B)
1 PCB blood level 1.641 0.355 21.350 0.00000** 5.159
2 PCQ blood level 8.235 1.844 19.949 0.00001** 3771.361
3 Blood sugar 
(increase)
0.038 0.011 11.310 0.00077** 1.038
4 Arthralgia 3.734 1.159 10.382 0.00127** 41.857
5 Gender (female) 3.456 1.115 9.605 0.00194** 31.679
6 T-bilirubin 
(increase)
-3.310 1.194 7.681 0.00558** 0.037
7 Black comedones 
(face)
-2.216 0.836 7.021 0.00806** 0.109
8 Past history of skin 
pigmentation
3.576 1.435 6.209 0.01271** 35.735
9A / G  r a t i o  
(decrease)
1.978 0.825 5.748 0.01651** 7.225
10 Acneform 
eruptions (trunk)
3.809 1.650 5.331 0.02095** 45.088
11 Respiratory 
sounds (abnormal)
6.036 2.780 4.714 0.02991** 418.145
12 Acneform 
eruptions 
(other sites)
-5.514 2.721 4.107 0.04270** 0.004
13 Potassium level 
(increase)
-1.849 0.917 4.071 0.04361** 0.157
14 Past history of 
acneform 
eruptions
-2.630 1.304 4.065 0.04378** 0.072
15 Total cholesterol 
(increase)
-0.023 0.011 3.910 0.04799** 0.978
16 Heart sound 
(abnormal)
13.341 7.892 2.857 0.09096* 621883.792
List of explanatory variables which showed less than 0.10 level of significance when PCB and PCQ blood levels were excluded from the explanatory 
variables in the above analysis
Explanatory 
variables
β Standard deviation Wald Significance
probability
Exp (B)
1 Past history of 
pigmentation
1.719 0.445 14.943 0.00011** 5.582
2 Age (old) 0.053 0.014 13.637 0.00022** 1.055
3A / G  r a t i o  
(decrease)
0.723 0.336 4.646 0.03113** 2.061
4 General fatigue -0.652 0.304 4.593 0.03211** 0.521
5 Arthralgia 0.633 0.299 4.478 0.03433** 1.884
6 Gender (female) 0.615 0.334 3.390 0.06558* 1.850
7 Pigmentation of 
the right buccal 
mucosa (band-like)
2.596 1.422 3.332 0.06793* 13.416
* P < 0.10, ** P < 0.05Environmental Health 2008, 7:47 http://www.ehjournal.net/content/7/1/47
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Table 5: Results of logistic regression analysis (PCB blood level as an objective variable)
Explanatory variables that showed less than 0.10 level of significance when the PCB blood level (2 categories) and factors selected by the principal 
components analysis were used as objective variables and explanatory variables, respectively
Explanatory 
variables
β Standard deviation Wald Significance
probability
Exp (B)
1 2,3,4,7,8-PeCDF 
blood level
0.012 0.003 15.412 0.00009** 1.012
2 Sputum -2.818 0.855 10.876 0.00097** 0.060
3 Age (old) 0.129 0.039 10.834 0.00100** 1.137
4 Past history of 
pigmentation
-3.832 1.167 10.783 0.00102** 0.022
5 Gender (female) -1.986 0.693 8.220 0.00414** 0.137
6 Past history of 
acneform 
eruptions
2.785 1.023 7.409 0.00649** 16.202
7 Pigmentation 
(toe nails)
-1.907 0.750 6.472 0.01096** 0.149
8 Hepatomegaly -7.627 3.134 5.920 0.01497** 0.000
9 Headache -1.554 0.704 4.871 0.02732** 0.211
10 Cheesy secretion 
from meibomian 
glands
2.623 1.248 4.414 0.03564** 13.773
11 Total bilirubin 
(increase)
-1.611 0.770 4.372 0.03654** 0.200
12 General fatigue 1.374 0.676 4.138 0.04194** 3.951
Explanatory variables which showed less than 0.10 level of significance when 2,3,4,7,8-PeCDF blood level was excluded from the explanatory 
variables in the above analysis
Explanatory 
variables
β Standard deviation Wald Significance
probability
Exp (B)
1 Age (old) 0.115 0.033 11.920 0.00056** 1.121
2 Sputum -2.040 0.663 9.473 0.00208** 0.130
3 Past history of 
pigmentation
-2.432 0.958 6.440 0.01116** 0.088
4 Total bilirubin 
(decrease)
-1.701 0.686 6.145 0.01318** 0.182
5 PCQ blood level 1.142 0.480 5.654 0.01742** 3.134
6 Pigmentation 
(toe nails)
-1.418 0.621 5.213 0.02242** 0.242
7 Arthralgia -4.886 2.357 4.299 0.03814** 0.008
8 Presence of a chief 
dental complaint
1.544 0.748 4.263 0.03896** 4.682
9 Headache -1.276 0.624 4.179 0.04093** 0.279
10 Cheesy secretion 
from meibomian 
glands
2.616 1.291 4.110 0.04264** 13.682
11 Past history of 
acneform 
eruptions
1.650 0.853 3.743 0.05304* 5.205
12 Black comedones -3.569 2.086 2.926 0.08716* 0.028
13 Mean corpuscular 
volume (increase)
-0.080 0.047 2.847 0.09154* 0.923
14 Urinalysis protein 
(increase)
-0.619 0.372 2.771 0.09600* 0.539
* P < 0.10, ** P < 0.05Environmental Health 2008, 7:47 http://www.ehjournal.net/content/7/1/47
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lesterol were significantly related to PCQ blood
concentration. The biochemical adverse effect of PCQ has
been reported to include increased triacylglycerol concen-
tration [20]. However, based on the results of this study,
total cholesterol concentration, one of the markers of
lipid metabolism such as triacylglycerol, was related to
PCQ blood concentration.
Like Kanemi Yusho, Taiwan Yucheng, a health hazard
caused by PCB or PCDFs, has been reported to have a high
incidence of symptoms of chloracne, goiter, arthritis, and
Table 6: Results of logistic regression analysis(PCQ blood levelas an objective variable)
Explanatory variables which showed less than 0.10 level of significance when PCQ blood level (2 categories) and the factors selected by the 
principal components analysis were used as objective variables and explanatory variables, respectively.
Explanatory 
variables
β Standard deviation Wald Significance
probability
Exp (B)
1 2,3,4,7,8-PeCDF 
blood level
0.040 0.010 16.276 0.00005** 1.041
2 Tooth pigmentation 6.737 2.073 10.564 0.00115** 843.324
3 Arthralgia -3.082 1.138 7.337 0.00675** 0.046
4 γ-GTP (increase) -0.065 0.024 7.132 0.00757** 0.937
5 Total bilirubin 
(decrease)
3.282 1.384 5.626 0.01769** 26.621
6 Cheesy secretion 
from meibomian 
glands
-7.612 3.230 5.554 0.01844** 0.000
7 General fatigue 2.983 1.273 5.497 0.01905** 19.756
8 Total cholesterol 
(increase)
0.042 0.018 5.260 0.02182** 1.043
9 Pigmentation 
(toe nails)
-3.974 1.906 4.348 0.03705** 0.019
10 Gender (female) -2.227 1.111 4.015 0.04509** 0.108
11 Pigmentation of the 
right buccal mucosa 
(band-like)
-7.584 3.846 3.889 0.04860** 0.001
12 Acneform 
eruptions 
(other sites)
8.124 4.436 3.354 0.06705* 3372.941
13 Headache -1.901 1.116 2.903 0.08842* 0.149
Explanatory variables which showed less than 0.10 level of significance when 2,3,4,7,8-PeCDF blood level was excluded from the explanatory 
variables in the above analysis
Explanatory 
variables
β Standard deviation Wald Significance
probability
Exp (B)
1 Past history of 
pigmentation
3.117 0.989 9.932 0.00162** 22.588
2 Tooth pigmentation 3.929 1.260 9.727 0.00182** 50.869
3 PCB blood level 0.437 0.156 7.842 0.00510** 1.547
4 Acneform 
eruptions (trunk)
-3.260 1.297 6.318 0.01195** 0.038
5 Abdominal pain -1.779 0.781 5.184 0.02280** 0.169
6 Pigmentation (face) 4.678 2.105 4.937 0.02629** 107.516
7 Total cholesterol 
(increase)
0.021 0.010 4.310 0.03790** 1.021
8 Acneform 
eruptions 
(other sites)
3.613 2.003 3.252 0.07132* 37.059
9 Pigmentation of the 
upper lip (patchy)
3.161 1.830 2.984 0.08407* 23.590
10 γ-GTP (increase) -0.021 0.013 2.721 0.09901* 0.980
* P < 0.10, ** P < 0.05Environmental Health 2008, 7:47 http://www.ehjournal.net/content/7/1/47
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anemia [21,22]. Chloracne and arthritis are considered e
symptoms common to Yusho and Taiwan Yucheng.
Health hazards caused by 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) in the Seveso (Italy) event have also been
studied. In a death survey, conducted 20–25 years after
the Seveso (Italy) event, a high incidence of deaths due to
cancer, circulatory disease, chronic obstructive pulmonary
disease (COPD), and diabetes mellitus was reported
[23,24]. It thus seems necessary to examine the presence
of a relationship between Yusho and COPD in the future,
since cough, sputum, and bursitis, included in the Yusho
criteria, are also symptoms seen in COPD.
Cutaneous, mucosal and ophthalmological manifesta-
tions, related to the blood concentrations of 2,3,4,7,8-
PeCDF, PCB and PCQ in this study, were considered char-
acteristic of Yusho and were included in the diagnostic cri-
teria.
Conclusion
Although 35 years have passed since the occurrence of
Yusho, the 2,3,4,7,8-PeCDF blood concentration
appeared related to the PCQ and PCB blood concentra-
tions, arthralgia and A/G ratio; The blood PCB concentra-
tion was strongly related to ophthalmological symptoms;
while PCQ blood concentration was related to total cho-
lesterol. These findings suggest that the co-contaminants
may affect other functions than those originally associated
with Yusho.
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